Pharmacy Department, National Cancer Institute, Putrajaya, 62250, Malaysia.
Pharmacy Department, National Cancer Institute, Putrajaya, 62250, Malaysia.
Appl Radiat Isot. 2024 Mar;205:111161. doi: 10.1016/j.apradiso.2023.111161. Epub 2023 Dec 27.
Due to increased demand, cyclotron has an expanding role in producing Gallium-68 (Ga) radiopharmaceuticals using solid and liquid targets. Though the liquid target produces lower end-of-bombardment activity compared to the solid target, our study presents the performance of Ga radiopharmaceuticals production using the liquid target by evaluating the end-of-bombardment activity and the end-of-purification activity of [Ga]GaCl. We also present the effect of increasing irradiation time, which significantly improves the end-of-synthesis yield. From the result obtained, the end-of-bombardment activity produced was 4.48 GBq, and the [Ga]GaCl end-of-purification activity produced was 2.51 GBq with below-limit metallic impurities. Increasing the irradiation time showed a significant increase in the end-of-synthesis activity from 1.33 GBq to 1.95 GBq for [Ga]Ga-PSMA-11 and from 1.13 GBq to 1.74 GBq for [Ga]Ga-DOTA-TATE. Based on the improvements made, the liquid target production of Ga radiopharmaceuticals is feasible and reproducible to accommodate up to 5 patients per production. In addition, this work also discusses the issues encountered, together with the possible corrective and preventative measures.
由于需求增加,回旋加速器在使用固体和液体靶材生产镓-68(Ga)放射性药物方面发挥着越来越重要的作用。虽然液体靶材产生的末端轰击中的放射性活度比固体靶材低,但我们的研究通过评估[Ga]GaCl 的末端轰击中的放射性活度和末端纯化中的放射性活度,展示了使用液体靶材生产 Ga 放射性药物的性能。我们还介绍了增加辐照时间的效果,这显著提高了合成末端的产率。从获得的结果来看,产生的末端轰击中的放射性活度为 4.48GBq,产生的[Ga]GaCl 末端纯化中的放射性活度为 2.51GBq,金属杂质低于限量。增加辐照时间使[Ga]Ga-PSMA-11 的合成末端的放射性活度从 1.33GBq 显著增加到 1.95GBq,使[Ga]Ga-DOTA-TATE 的合成末端的放射性活度从 1.13GBq 增加到 1.74GBq。基于所做的改进,液体靶材生产 Ga 放射性药物是可行的且可重复的,可以满足每次生产多达 5 名患者的需求。此外,这项工作还讨论了遇到的问题,以及可能的纠正和预防措施。